Profile, Breath respiratory deals

Breath (London, U.K.) granted Profile Therapeutics (LSE:PTP) a license to market Breath's inhaled generic respiratory drugs in Europe. Breath is a subsidiary of Arrow Group (London, U.K). The drugs will be marketed under PTP's own brand and includes an inhaled corticosteroid, a bronchodilator and an anticholinergic, which are used to treat respiratory diseases such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). The products will be launched in late 2004. ...